MENU
YMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Y-mAbs Therapeutics (YMAB) Ownership - Who owns Y-mAbs Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
662.75M
P/E Ratio
N/A
Total Cash
77.81M
Projected Growth
N/A
Total Debt
1.27M
Revenue
86.55M
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash/Share
1.75
Total Debt/Equity
N/A
Revenue/Share
1.98 USD as % of share price
Fundamentals
YMAB
Capitalization
663M
P/E Ratio
N/A
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash
77.8M
Total Cash/Share
1.75
Total Debt
1.27M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.98%
Revenue
86.5M
ROE
N/A
Book Value
95.3M
P/B Ratio
6.95
Cash Flow
N/A
Earnings
-0.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
2.92
Current Revenue Per Employee
227980.00
Dividends Per Share - Security
N/A
EBITDA
-27M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.78
Revenue To Assets
-17.81
Shares Held By Institutions
464M
Shares Outstanding - Current
44.6M
Total Liabilities
48.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
118.035
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel antibody therapeutics for oncology targets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com